Home > Financial Ratios > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Fixed Capital/Sales

    Back to All Ratios
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2013Mar2012
   Fixed Capital/Sales(x) 0.820.890.620.480.45

What is the latest Fixed Capital/Sales ratio of NATH BIOGENES (INDIA) ?

The latest Fixed Capital/Sales ratio of NATH BIOGENES (INDIA) is 0.82 based on Mar2024 Consolidated results.
Year Fixed Capital/Sales
Mar20240.82
Mar20230.89
Mar20220.62
Mar20130.48
Mar20120.45

How is Fixed Capital/Sales of NATH BIOGENES (INDIA) Trending?

Years Fixed Capital/Sales % Change
Mar2024 0.82
-7.87
Mar2023 0.89
43.55
Mar2022 0.62
29.17
Mar2013 0.48
6.67
Mar2012 0.45 -

Other Financial Ratios of NATH BIOGENES (INDIA)


Compare Fixed Capital/Sales ratio of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹286.3 Cr -6.4% -10.1% -25% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹11,592.2 Cr -9.5% -21.2% -0.4% Stock Analytics
KAVERI SEED COMPANY ₹5,148.0 Cr 2.1% 11% 55.9% Stock Analytics
VENKYS (INDIA) ₹2,301.8 Cr -1.3% -9.9% -9.1% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹1,405.4 Cr -7% -12.6% -38.5% Stock Analytics
INDO US BIOTECH ₹394.8 Cr -9.8% -10.3% -14.4% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

-6.4%

-10.1%

-25%

SENSEX

-3.4%

-4.4%

0.6%


You may also like the below Video Courses